Market Access Insights
Access the relevant market access data and insights you need on health plans, policy restrictions, PBMs, providers, and more
Formulary Advantages Among Monoclonal Antibodies in Oncology: Health plans report high priority on reducing oncology drug costs.
While we forecast sales of oncology drugs in the United States to grow at a compound annual growth rate of 4.4% between now and 2016, we forecast sales of monoclonal antibodies (MAbs) in oncology to g…
Formulary Advantages in Multiple Sclerosis: How will price impact the uptake of emerging orally-delivered therapies?
Multiple sclerosis (MS), an inflammatory disease of the central nervous system, is characterized by progressive neuronal loss and worsening physical disability. Although there are a number of currentl…